nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMS—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.00517	0.134	CbGdCrCtD
Floxuridine—TYMS—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.00517	0.134	CbGdCrCtD
Floxuridine—TYMS—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.00392	0.102	CbGdCrCtD
Floxuridine—TYMS—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00361	0.0937	CbGdCrCtD
Floxuridine—TYMS—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00361	0.0937	CbGdCrCtD
Floxuridine—TYMS—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00361	0.0937	CbGdCrCtD
Floxuridine—TYMS—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00361	0.0937	CbGdCrCtD
Floxuridine—TYMS—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00274	0.071	CbGdCrCtD
Floxuridine—TYMS—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00274	0.071	CbGdCrCtD
Floxuridine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00201	0.00212	CcSEcCtD
Floxuridine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00201	0.00212	CcSEcCtD
Floxuridine—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.0021	CcSEcCtD
Floxuridine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00199	0.00209	CcSEcCtD
Floxuridine—Glossitis—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00207	CcSEcCtD
Floxuridine—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00197	0.00207	CcSEcCtD
Floxuridine—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00196	0.00207	CcSEcCtD
Floxuridine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00196	0.00206	CcSEcCtD
Floxuridine—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00195	0.00206	CcSEcCtD
Floxuridine—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00192	0.00202	CcSEcCtD
Floxuridine—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00191	0.00201	CcSEcCtD
Floxuridine—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00191	0.00201	CcSEcCtD
Floxuridine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00199	CcSEcCtD
Floxuridine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00185	0.00195	CcSEcCtD
Floxuridine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00193	CcSEcCtD
Floxuridine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00193	CcSEcCtD
Floxuridine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00183	0.00192	CcSEcCtD
Floxuridine—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00192	CcSEcCtD
Floxuridine—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00191	CcSEcCtD
Floxuridine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00181	0.00191	CcSEcCtD
Floxuridine—Rash maculo-papular—Epirubicin—peripheral nervous system neoplasm	0.00178	0.00188	CcSEcCtD
Floxuridine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00178	0.00187	CcSEcCtD
Floxuridine—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00177	0.00186	CcSEcCtD
Floxuridine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00175	0.00185	CcSEcCtD
Floxuridine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00175	0.00184	CcSEcCtD
Floxuridine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00174	0.00183	CcSEcCtD
Floxuridine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00183	CcSEcCtD
Floxuridine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00183	CcSEcCtD
Floxuridine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00182	CcSEcCtD
Floxuridine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00182	CcSEcCtD
Floxuridine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00181	CcSEcCtD
Floxuridine—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.0017	0.00179	CcSEcCtD
Floxuridine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00169	0.00178	CcSEcCtD
Floxuridine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00169	0.00178	CcSEcCtD
Floxuridine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00168	0.00177	CcSEcCtD
Floxuridine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00168	0.00177	CcSEcCtD
Floxuridine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00167	0.00176	CcSEcCtD
Floxuridine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00176	CcSEcCtD
Floxuridine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00176	CcSEcCtD
Floxuridine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00176	CcSEcCtD
Floxuridine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00176	CcSEcCtD
Floxuridine—Rash maculo-papular—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00174	CcSEcCtD
Floxuridine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00174	CcSEcCtD
Floxuridine—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00173	CcSEcCtD
Floxuridine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00165	0.00173	CcSEcCtD
Floxuridine—TYMS—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.00162	0.0421	CbGdCrCtD
Floxuridine—TYMS—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00162	0.0421	CbGdCrCtD
Floxuridine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00171	CcSEcCtD
Floxuridine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00161	0.0017	CcSEcCtD
Floxuridine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00161	0.00169	CcSEcCtD
Floxuridine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.00168	CcSEcCtD
Floxuridine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00167	CcSEcCtD
Floxuridine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00165	CcSEcCtD
Floxuridine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00157	0.00165	CcSEcCtD
Floxuridine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00165	CcSEcCtD
Floxuridine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00164	CcSEcCtD
Floxuridine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00164	CcSEcCtD
Floxuridine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00155	0.00164	CcSEcCtD
Floxuridine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00155	0.00163	CcSEcCtD
Floxuridine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00163	CcSEcCtD
Floxuridine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00154	0.00162	CcSEcCtD
Floxuridine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00154	0.00162	CcSEcCtD
Floxuridine—Infection—Vincristine—peripheral nervous system neoplasm	0.00153	0.00161	CcSEcCtD
Floxuridine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00153	0.00161	CcSEcCtD
Floxuridine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00161	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.0016	CcSEcCtD
Floxuridine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00152	0.00159	CcSEcCtD
Floxuridine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00152	0.00159	CcSEcCtD
Floxuridine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00151	0.00159	CcSEcCtD
Floxuridine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00151	0.00159	CcSEcCtD
Floxuridine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00151	0.00159	CcSEcCtD
Floxuridine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00158	CcSEcCtD
Floxuridine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.0015	0.00158	CcSEcCtD
Floxuridine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00157	CcSEcCtD
Floxuridine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.0015	0.00157	CcSEcCtD
Floxuridine—TYMP—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00148	0.13	CbGpPWpGaD
Floxuridine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00147	0.00155	CcSEcCtD
Floxuridine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00147	0.00155	CcSEcCtD
Floxuridine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00146	0.00153	CcSEcCtD
Floxuridine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00153	CcSEcCtD
Floxuridine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00152	CcSEcCtD
Floxuridine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00152	CcSEcCtD
Floxuridine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00143	0.0015	CcSEcCtD
Floxuridine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.0015	CcSEcCtD
Floxuridine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00142	0.0015	CcSEcCtD
Floxuridine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00141	0.00149	CcSEcCtD
Floxuridine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00141	0.00149	CcSEcCtD
Floxuridine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00148	CcSEcCtD
Floxuridine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00146	CcSEcCtD
Floxuridine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00138	0.00145	CcSEcCtD
Floxuridine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00137	0.00144	CcSEcCtD
Floxuridine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Floxuridine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Floxuridine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Floxuridine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00143	CcSEcCtD
Floxuridine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00135	0.00142	CcSEcCtD
Floxuridine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00142	CcSEcCtD
Floxuridine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Floxuridine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Floxuridine—Rash—Topotecan—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Floxuridine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Floxuridine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Floxuridine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Floxuridine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Floxuridine—Headache—Topotecan—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Floxuridine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Floxuridine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Floxuridine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Floxuridine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Floxuridine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Floxuridine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Floxuridine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Floxuridine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Floxuridine—Rash—Melphalan—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Floxuridine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Floxuridine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Floxuridine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00137	CcSEcCtD
Floxuridine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00137	CcSEcCtD
Floxuridine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00129	0.00136	CcSEcCtD
Floxuridine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Floxuridine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00133	CcSEcCtD
Floxuridine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00133	CcSEcCtD
Floxuridine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00126	0.00133	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00126	0.00133	CcSEcCtD
Floxuridine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00133	CcSEcCtD
Floxuridine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00126	0.00133	CcSEcCtD
Floxuridine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00132	CcSEcCtD
Floxuridine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00132	CcSEcCtD
Floxuridine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00125	0.00132	CcSEcCtD
Floxuridine—Infection—Etoposide—peripheral nervous system neoplasm	0.00124	0.00131	CcSEcCtD
Floxuridine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.0013	CcSEcCtD
Floxuridine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00124	0.0013	CcSEcCtD
Floxuridine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00122	0.00129	CcSEcCtD
Floxuridine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Floxuridine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Floxuridine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Floxuridine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00126	CcSEcCtD
Floxuridine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00119	0.00125	CcSEcCtD
Floxuridine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00125	CcSEcCtD
Floxuridine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00124	CcSEcCtD
Floxuridine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00124	CcSEcCtD
Floxuridine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00123	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00123	CcSEcCtD
Floxuridine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00121	CcSEcCtD
Floxuridine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00114	0.0012	CcSEcCtD
Floxuridine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
Floxuridine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
Floxuridine—TYMS—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00112	0.029	CbGdCrCtD
Floxuridine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00117	CcSEcCtD
Floxuridine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00111	0.00116	CcSEcCtD
Floxuridine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00116	CcSEcCtD
Floxuridine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00115	CcSEcCtD
Floxuridine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00115	CcSEcCtD
Floxuridine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00109	0.00114	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00114	CcSEcCtD
Floxuridine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00113	CcSEcCtD
Floxuridine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00113	CcSEcCtD
Floxuridine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00106	0.00111	CcSEcCtD
Floxuridine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00109	CcSEcCtD
Floxuridine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00109	CcSEcCtD
Floxuridine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00103	0.00108	CcSEcCtD
Floxuridine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00108	CcSEcCtD
Floxuridine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Floxuridine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Floxuridine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Floxuridine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Floxuridine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Floxuridine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.001	0.00106	CcSEcCtD
Floxuridine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00106	CcSEcCtD
Floxuridine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000991	0.00104	CcSEcCtD
Floxuridine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00099	0.00104	CcSEcCtD
Floxuridine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000988	0.00104	CcSEcCtD
Floxuridine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000988	0.00104	CcSEcCtD
Floxuridine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000986	0.00104	CcSEcCtD
Floxuridine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000981	0.00103	CcSEcCtD
Floxuridine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000978	0.00103	CcSEcCtD
Floxuridine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000978	0.00103	CcSEcCtD
Floxuridine—Rash—Vincristine—peripheral nervous system neoplasm	0.000972	0.00102	CcSEcCtD
Floxuridine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000972	0.00102	CcSEcCtD
Floxuridine—Headache—Vincristine—peripheral nervous system neoplasm	0.000966	0.00102	CcSEcCtD
Floxuridine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000958	0.00101	CcSEcCtD
Floxuridine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000951	0.001	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000948	0.000998	CcSEcCtD
Floxuridine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000933	0.000982	CcSEcCtD
Floxuridine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00092	0.000969	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000917	0.000965	CcSEcCtD
Floxuridine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000916	0.000964	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000912	0.00096	CcSEcCtD
Floxuridine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000905	0.000953	CcSEcCtD
Floxuridine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000896	0.000944	CcSEcCtD
Floxuridine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000871	0.000917	CcSEcCtD
Floxuridine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000867	0.000913	CcSEcCtD
Floxuridine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00086	0.000905	CcSEcCtD
Floxuridine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000859	0.000904	CcSEcCtD
Floxuridine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000858	0.000903	CcSEcCtD
Floxuridine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000855	0.0009	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.000851	0.0746	CbGpPWpGaD
Floxuridine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000825	0.000868	CcSEcCtD
Floxuridine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00081	0.000853	CcSEcCtD
Floxuridine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000806	0.000848	CcSEcCtD
Floxuridine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000796	0.000838	CcSEcCtD
Floxuridine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000794	0.000836	CcSEcCtD
Floxuridine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000794	0.000836	CcSEcCtD
Floxuridine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000793	0.000835	CcSEcCtD
Floxuridine—Rash—Etoposide—peripheral nervous system neoplasm	0.000788	0.000829	CcSEcCtD
Floxuridine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000787	0.000828	CcSEcCtD
Floxuridine—Headache—Etoposide—peripheral nervous system neoplasm	0.000783	0.000824	CcSEcCtD
Floxuridine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000774	0.000815	CcSEcCtD
Floxuridine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000768	0.000809	CcSEcCtD
Floxuridine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000763	0.000804	CcSEcCtD
Floxuridine—TYMS—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.000757	0.0664	CbGpPWpGaD
Floxuridine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000742	0.000781	CcSEcCtD
Floxuridine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.000775	CcSEcCtD
Floxuridine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000734	0.000772	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—peripheral nervous system neoplasm	0.000729	0.0639	CbGpPWpGaD
Floxuridine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000722	0.00076	CcSEcCtD
Floxuridine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000716	0.000754	CcSEcCtD
Floxuridine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.000748	CcSEcCtD
Floxuridine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000706	0.000743	CcSEcCtD
Floxuridine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.0007	0.000737	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—ERBB2—peripheral nervous system neoplasm	0.000697	0.0611	CbGpPWpGaD
Floxuridine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000696	0.000732	CcSEcCtD
Floxuridine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000687	0.000723	CcSEcCtD
Floxuridine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000722	CcSEcCtD
Floxuridine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000668	0.000703	CcSEcCtD
Floxuridine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000703	CcSEcCtD
Floxuridine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000653	0.000688	CcSEcCtD
Floxuridine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000648	0.000682	CcSEcCtD
Floxuridine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000678	CcSEcCtD
Floxuridine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000669	CcSEcCtD
Floxuridine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000634	0.000668	CcSEcCtD
Floxuridine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.00065	CcSEcCtD
Floxuridine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000641	CcSEcCtD
Floxuridine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000607	CcSEcCtD
Floxuridine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000603	CcSEcCtD
Floxuridine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000593	CcSEcCtD
Floxuridine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000583	CcSEcCtD
Floxuridine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000583	CcSEcCtD
Floxuridine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000562	CcSEcCtD
Floxuridine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.000558	CcSEcCtD
Floxuridine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000543	CcSEcCtD
Floxuridine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000539	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000539	CcSEcCtD
Floxuridine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000529	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—MYC—peripheral nervous system neoplasm	0.000494	0.0433	CbGpPWpGaD
Floxuridine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000504	CcSEcCtD
Floxuridine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000503	CcSEcCtD
Floxuridine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000489	CcSEcCtD
Floxuridine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000469	CcSEcCtD
Floxuridine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000467	CcSEcCtD
Floxuridine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000465	CcSEcCtD
Floxuridine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000464	CcSEcCtD
Floxuridine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000462	CcSEcCtD
Floxuridine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000438	CcSEcCtD
Floxuridine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000434	CcSEcCtD
Floxuridine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.00043	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00043	CcSEcCtD
Floxuridine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000427	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—TP53—peripheral nervous system neoplasm	0.000405	0.0356	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—HRAS—peripheral nervous system neoplasm	0.000388	0.034	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000386	0.0338	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000405	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00037	0.0324	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000287	0.0252	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000197	0.0173	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000194	0.017	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000188	0.0165	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000181	0.0159	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000178	0.0156	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000165	0.0145	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000159	0.0139	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000151	0.0133	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000149	0.013	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000147	0.0129	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GNS—peripheral nervous system neoplasm	0.00014	0.0123	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NME1—peripheral nervous system neoplasm	0.000134	0.0118	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—COX2—peripheral nervous system neoplasm	0.000129	0.0113	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000127	0.0112	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000115	0.0101	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000111	0.00971	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.92e-05	0.0087	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	9.81e-05	0.0086	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—MYC—peripheral nervous system neoplasm	9.24e-05	0.0081	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	9.08e-05	0.00797	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—AURKA—peripheral nervous system neoplasm	8.77e-05	0.00769	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ENO2—peripheral nervous system neoplasm	8.49e-05	0.00745	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	8.32e-05	0.0073	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CHEK2—peripheral nervous system neoplasm	7.84e-05	0.00688	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	7.78e-05	0.00683	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.55e-05	0.00663	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—BCHE—peripheral nervous system neoplasm	7.18e-05	0.0063	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GNS—peripheral nervous system neoplasm	7.17e-05	0.00629	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NME1—peripheral nervous system neoplasm	6.87e-05	0.00603	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.85e-05	0.00601	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—TH—peripheral nervous system neoplasm	6.75e-05	0.00592	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—COX2—peripheral nervous system neoplasm	6.62e-05	0.00581	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	6.36e-05	0.00558	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.9e-05	0.00517	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—BIRC5—peripheral nervous system neoplasm	5.68e-05	0.00499	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GNAS—peripheral nervous system neoplasm	5.51e-05	0.00483	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCB1—peripheral nervous system neoplasm	5.4e-05	0.00474	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.84e-05	0.00425	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.65e-05	0.00408	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ENO2—peripheral nervous system neoplasm	4.34e-05	0.00381	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	4.21e-05	0.0037	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.09e-05	0.00359	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	3.77e-05	0.0033	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—BCHE—peripheral nervous system neoplasm	3.67e-05	0.00322	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.5e-05	0.00307	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—TH—peripheral nervous system neoplasm	3.45e-05	0.00303	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	2.85e-05	0.0025	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GNAS—peripheral nervous system neoplasm	2.82e-05	0.00247	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCB1—peripheral nervous system neoplasm	2.76e-05	0.00243	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—peripheral nervous system neoplasm	2.55e-05	0.00224	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—peripheral nervous system neoplasm	2.1e-05	0.00184	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—peripheral nervous system neoplasm	1.49e-05	0.0013	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—peripheral nervous system neoplasm	7.6e-06	0.000667	CbGpPWpGaD
